Difference between revisions of "COL1A2-AS1"

From LncRNAWiki
Jump to: navigation, search
(Created page with "==Annotated Information== ===Approved Symbol=== COL1A2-AS1 ===Approved Name=== COL1A2 antisense RNA 1 ===Previous Symbols=== _ ===Synonyms=== "TCONS_00013888, lncRNA8975-1" ==...")
 
Line 1: Line 1:
 +
 
==Annotated Information==
 
==Annotated Information==
===Approved Symbol===
+
===Name===
COL1A2-AS1
+
COL1A2-AS1:COL1A2 antisense RNA 1
===Approved Name===
+
 
COL1A2 antisense RNA 1
+
LncRNA8975-1<ref name="ref1" />
===Previous Symbols===
+
===Characteristics===
_
+
LncRNA8975-1(TCONS_00013888 in UCSC hg38; also named NONHSAT122029 in NONCODEv4) is an lncRNA located upstream of the COL1A2 gene on chromosome 7(UCSC hg38, chr7:94278999-94392179, ChIPBase named it lncRNA8975-1). In addition, lncRNA8975-1 is a transcript of 352 nucleotides and comprises 5 exons(NONHSAT122029 in NONCODEv4) based on bioinformatics analyses. LncRNA8975-1 contains no overlapping sequence with the transcripts from its neighbouring gene COL1A2 and is a natural antisense lncRNA. <ref name="ref1" />
===Synonyms===
+
 
"TCONS_00013888, lncRNA8975-1"
+
===Function===
===Chromosome===
+
[[
7q21.3
+
Dysregulation of lncRNA8975-1 can affect collagen and α-SMA expression in fibroblasts. Further more, knockdown of lncRNA8975-1 significantly increases cell proliferation, whereas overexpression of lncRNA8975-1 inhibits HSF cell proliferation.<ref name="ref1" />
===RefSeq ID===
+
===Expression===
_
+
[[
===OMIM ID===
+
The expression of lncRNA8975-1 is significantly overexpressed in hypertrophic scar tissues compared to normal skin tissues. Furthermore, lncRNA8975-1 expression in hypertrophic scar fibroblasts (HSF) is higher than in normal skin fibroblasts (NSF). <ref name="ref1" />
_
+
 
===RefSeq(supplied by NCBI)===
+
==Labs working on this lncRNA==
XR_001745273
+
*State key Laboratory of Reproductive Medicine, Department of Plastic&amp;Cosmetic Surgery, Maternal and Child Health Medical Institute, Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University, Nanjing, China.
===pubmed IDs===
+
==References==
27866191
+
<references>
 +
<ref name="ref1">
 +
Li J, Chen L, Cao C, Yan H, Zhou B, Gao Y, Li Q, Li J. The Long Non-Coding RNA
 +
LncRNA8975-1 is Upregulated in Hypertrophic Scar Fibroblasts and Controls
 +
Collagen Expression. Cell Physiol Biochem. 2016;40(1-2):326-334.
 +
</ref>
 +
</references>

Revision as of 07:16, 25 October 2017

Annotated Information

Name

COL1A2-AS1:COL1A2 antisense RNA 1

LncRNA8975-1[1]

Characteristics

LncRNA8975-1(TCONS_00013888 in UCSC hg38; also named NONHSAT122029 in NONCODEv4) is an lncRNA located upstream of the COL1A2 gene on chromosome 7(UCSC hg38, chr7:94278999-94392179, ChIPBase named it lncRNA8975-1). In addition, lncRNA8975-1 is a transcript of 352 nucleotides and comprises 5 exons(NONHSAT122029 in NONCODEv4) based on bioinformatics analyses. LncRNA8975-1 contains no overlapping sequence with the transcripts from its neighbouring gene COL1A2 and is a natural antisense lncRNA. [1]

Function

[[ Dysregulation of lncRNA8975-1 can affect collagen and α-SMA expression in fibroblasts. Further more, knockdown of lncRNA8975-1 significantly increases cell proliferation, whereas overexpression of lncRNA8975-1 inhibits HSF cell proliferation.[1]

Expression

[[ The expression of lncRNA8975-1 is significantly overexpressed in hypertrophic scar tissues compared to normal skin tissues. Furthermore, lncRNA8975-1 expression in hypertrophic scar fibroblasts (HSF) is higher than in normal skin fibroblasts (NSF). [1]

Labs working on this lncRNA

  • State key Laboratory of Reproductive Medicine, Department of Plastic&Cosmetic Surgery, Maternal and Child Health Medical Institute, Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University, Nanjing, China.

References

  1. 1.0 1.1 1.2 1.3 Li J, Chen L, Cao C, Yan H, Zhou B, Gao Y, Li Q, Li J. The Long Non-Coding RNA LncRNA8975-1 is Upregulated in Hypertrophic Scar Fibroblasts and Controls Collagen Expression. Cell Physiol Biochem. 2016;40(1-2):326-334.